{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:42:05Z","timestamp":1765294925868,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.urolonc.2017.12.005","type":"journal-article","created":{"date-parts":[[2017,12,26]],"date-time":"2017-12-26T09:21:07Z","timestamp":1514280067000},"page":"158.e7-158.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Targeted antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy during active surveillance: Effect on hospitalization"],"prefix":"10.1016","volume":"36","author":[{"given":"Carling","family":"Cheung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiten D.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Landis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Ballentine","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misop","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2017.12.005_bib1","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.juro.2011.06.057","article-title":"Complications after prostate biopsy: data from SEER-Medicare","volume":"186","author":"Loeb","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2017.12.005_bib2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.puhe.2016.10.006","article-title":"Risk of hospitalization and death following prostate biopsy in Scotland","volume":"142","author":"Brewster","year":"2017","journal-title":"Public Health"},{"key":"10.1016\/j.urolonc.2017.12.005_bib3","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.eururo.2013.05.049","article-title":"Systematic review of complications of prostate biopsy","volume":"64","author":"Loeb","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2017.12.005_bib4","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.juro.2014.08.008","article-title":"Fluoroquinolone resistance in the rectal carriage of men in an active surveillance cohort: longitudinal analysis","volume":"193","author":"Cohen","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2017.12.005_bib5","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1159\/000448595","article-title":"Impact of rectal swabs on INFECTIOUS Complications after transrectal prostate biopsy","volume":"97","author":"Trujillo","year":"2016","journal-title":"Urol Int"},{"key":"10.1016\/j.urolonc.2017.12.005_bib6","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/bju.13402","article-title":"The role of targeted prophylactic antimicrobial therapy before transrectal ultrasonography\u2010guided prostate biopsy in reducing infection rates: a systematic review","volume":"117","author":"Cussans","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2017.12.005_bib7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ucl.2015.06.005","article-title":"Preprostate biopsy rectal culture and postbiopsy sepsis","volume":"42","author":"Taylor","year":"2015","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urolonc.2017.12.005_bib8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.juro.2015.03.110","article-title":"Comparative effectiveness of targeted vs empirical antibiotic prophylaxis to prevent sepsis from transrectal prostate biopsy: a retrospective analysis","volume":"194","author":"Liss","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2017.12.005_bib9","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s00345-015-1571-y","article-title":"An antimicrobial prophylaxis protocol using rectal swab cultures for transrectal prostate biopsy","volume":"33","author":"Summers","year":"2015","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2017.12.005_bib10","doi-asserted-by":"crossref","first-page":"5392107","DOI":"10.1155\/2016\/5392107","article-title":"Prevalence, risk factors, and clinical relevance of fluoroquinolone-resistant organisms in rectal cultures: should we target antibiotic prophylaxis prior to prostate biopsy?","volume":"2016","author":"Van Besien","year":"2016","journal-title":"Adv Urol"},{"key":"10.1016\/j.urolonc.2017.12.005_bib11","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1200\/JCO.2015.62.5764","article-title":"Intermediate and longer-term outcomes from a prospective active-surveillance program for favorable-risk prostate cancer","volume":"33","author":"Tosoian","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2017.12.005_bib12","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.juro.2008.01.068","article-title":"Best practice policy statement on urologic surgery antimicrobial prophylaxis","volume":"179","author":"Wolf","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2017.12.005_bib13","unstructured":"Cost to Charge Ratio High Values for FY 2016. U.S. Department of Labor. https:\/\/www.dol.gov\/owcp\/regs\/feeschedule\/fee\/fee15\/CCR_Table_FY_2016.htm. Accessed 21.11.17"},{"key":"10.1016\/j.urolonc.2017.12.005_bib14","doi-asserted-by":"crossref","first-page":"E86","DOI":"10.1111\/j.1464-410X.2011.10768.x","article-title":"Cost-effectiveness of standard vs intensive antibiotic regimens for transrectal ultrasonography (TRUS)-guided prostate biopsy prophylaxis","volume":"110","author":"Adibi","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2017.12.005_bib15","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.juro.2009.11.043","article-title":"Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy","volume":"183","author":"Nam","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2017.12.005_bib16","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.juro.2010.11.088","article-title":"Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy","volume":"185","author":"Liss","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2017.12.005_bib17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000296290","article-title":"Is it possible to predict sepsis, the most serious complication in prostate biopsy?","volume":"84","author":"Simsir","year":"2010","journal-title":"Urol Int"},{"key":"10.1016\/j.urolonc.2017.12.005_bib18","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1464-410X.2012.11637.x","article-title":"Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy","volume":"111","author":"Taylor","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2017.12.005_bib19","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0090-4295(99)80353-7","article-title":"The influence of prostate size on cancer detection","volume":"46","author":"Uzzo","year":"1995","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2017.12.005_bib20","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.juro.2013.09.029","article-title":"Prostate specific antigen velocity risk count predicts biopsy reclassification for men with very low risk prostate cancer","volume":"191","author":"Patel","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2017.12.005_bib21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/pcan.2017.16","article-title":"Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillance","volume":"20","author":"Tosoian","year":"2017","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2017.12.005_bib22","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.juro.2011.11.115","article-title":"Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care","volume":"187","author":"Taylor","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2017.12.005_bib23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000314340","article-title":"Does washing the biopsy needle with povidone-iodine have an effect on infection rates after transrectal prostate needle biopsy?","volume":"85","author":"Koc","year":"2010","journal-title":"Urol Int"},{"key":"10.1016\/j.urolonc.2017.12.005_bib24","unstructured":"Gonzalez CT, Averch T, Boyd L, Clemens J, Dowling R, Goldman H AUA\/SUNA white paper on the incidence, prevention and treatment of complications related to prostate needle biopsy. in American Urological Association. 2012."},{"key":"10.1016\/j.urolonc.2017.12.005_bib25","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.urology.2011.02.065","article-title":"Long-term fluoroquinolone use before the prostate biopsy may increase the risk of sepsis caused by resistant microorganisms","volume":"78","author":"Akduman","year":"2011","journal-title":"Urology"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143917306166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143917306166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:13:08Z","timestamp":1761041588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143917306166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1078143917306166"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2017.12.005","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy during active surveillance: Effect on hospitalization","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2017.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}